"Androstenols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.
| Descriptor ID |
D000737
|
| MeSH Number(s) |
D04.210.500.054.079.429
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Androstenols".
Below are MeSH descriptors whose meaning is more specific than "Androstenols".
This graph shows the total number of publications written about "Androstenols" by people in this website by year, and whether "Androstenols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstenols" by people in Profiles.
-
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. J Clin Oncol. 2012 Feb 20; 30(6):637-43.
-
Novel therapies for metastatic castrate-resistant prostate cancer. J Natl Cancer Inst. 2011 Nov 16; 103(22):1665-75.
-
Abiraterone acetate. Nat Rev Drug Discov. 2011 Aug 01; 10(8):573-4.
-
Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011 May 26; 364(21):1995-2005.